Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

New Jersey Proposes Medical Marijuana Reimbursements in Workers’ Comp

Two new companion bills carryover similar marijuana reimbursement proposals from 2024.
Read More →
March 23, 2026

Louisiana Reform Package Proposes Centralized Medical Authorization Database

Additionally, the bill would update the fee schedule and impact billing and utilization requirements.
Read More →
March 23, 2026

South Carolina Approves 2026 Fee Schedule and Targets IMEs

The updated fee schedule will go into effect April 1st, while a new IME subcommittee will evaluate cost and practice concerns.
Read More →
March 23, 2026

American Medical Association Reports on Increased Physician AI Use

Over 80% of physician respondents currently use AI in a professional context – double the share reported in 2023.
Read More →
March 23, 2026

Massachusetts Announces Draft Fee Schedule Rules

At a March 11th meeting, the Workers’ Compensation Advisory Council announced a draft expected in fall of 2026 for public comments.
Read More →
March 16, 2026

New York Considers Update to Pharmacy Rules

The bill would allow injured workers to obtain medication from out-of-network pharmacies when specific conditions occur.
Read More →
March 16, 2026

WCRI Panel Flags Key Challenges

An employer panel discussed issues such as access to care, early intervention practices, and claims culture and communication.
Read More →
March 16, 2026

Alabama Considers Covering Parkinson’s Disease for Firefighters

The bill includes standards for demonstrating that the disease is occupational in origin, and if enacted it would go into effect October 1st.
Read More →
March 16, 2026

Florida Advances AI Oversight in Insurance and Work Comp Claims

Florida House Bill 527 is moving quickly in the face of a March 13th deadline.
Read More →
March 9, 2026
1 2 3 4 … 48

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

The Cost of Exposure: How Occupational Cancer Impacts Workers’ Compensation

The risk and impact of occupational cancers vary significantly depending on the nature of the exposure and the affected workforce.
Read More

Utah Launches AI Prescription Renewal Pilot Program for Chronic Conditions

The pilot can approve a limited set of 192 medications and will be broken into three stages, each with different levels of review.
Read More

States Seek to Limit AI-Generated Care Decisions, Despite White House Order

Legislators continue to introduce bills to limit AI-generated healthcare decisions, even as the U.S. Attorney General has been instructed to oppose them.
Read More

White House Issues Executive Order to Reschedule Marijuana

Rescheduling marijuana to Schedule III will allow for greater clinical research, possible FDA-approved drugs, and more.
Read More

States Consider Expanding Presumptions

So far in 2026, eight states and counting are seeking to expand existing presumptions or create new presumptions.
Read More

Could AI-Designed Drugs Impact Regulatory Frameworks?

While AI can be effective in some elements of drug design, AI models currently struggle to explain their decision making, a key component of drug review.
Read More
1 2 3 4 … 50
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle